StockMarketWire.com - Mediclinic International said its largest two platforms, Switzerland and Southern Africa, in addition to its Dubai business, performed in line with expectations during FY 2017, but its Abu Dhabi business underperformed.

The Abu Dhabi business was impacted by a major regulatory change in addition to certain business and operational challenges.

"We have been focused on resolving these issues and stabilising performance in the Middle East," said chief executive Danie Meintjes.

"Our confidence in the long-term growth opportunities of the region remains strong and we currently expect performance in the Middle East to improve as we progress through the 2018 financial year," he said.






Story provided by StockMarketWire.com